KDL(SH:603987) Ge Long Hui A P P·2025-09-02 10:48Core Viewpoint - Kangdelai Group aims to deepen its strategic layout and promote collaborative win-win goals through a share transfer agreement with Changsha Medical Investment Co., Ltd. [1] Summary by Relevant Sections - Share Transfer Agreement - Kangdelai's controlling shareholder, Shanghai Kangdelai Holding Group Co., Ltd., signed a share transfer agreement on September 1, 2025, to transfer 21,839,544 shares (5% of total share capital) to Changsha Medical Investment at a price of 10.81 yuan per share, totaling 236,085,470.64 yuan [1] - Commitment from the Buyer - Changsha Medical Investment voluntarily commits not to reduce its holdings of the acquired shares for 12 months following the completion of the transfer [1] - Impact on Company Control - The share transfer does not involve a tender offer and will not lead to changes in the controlling shareholder or actual controller of the company, ensuring no adverse effects on the company's ongoing stable operations [1]